The Hope and Hype of CRISPR-Cas9 Genome Editing
Author:
- 1 August 2017
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 2 (8) , 914-919
Abstract
Importance Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (CRISPR-Cas9) has garnered a great degree of attention since its first reported uses in mammalian cells in early 2013 due to its perceived impact with respect to potential research applications and, especially, therapeutic applications. Observations CRISPR-Cas9 is being widely used in the laboratory and has greatly improved the ability to generate genetically modified animal models of human diseases. First steps have been reported with respect to proof-of-concept cardiovascular therapeutic applications in mouse models—which might eventually lead to new treatments for patients—as well as modification of human embryos, which raises a host of social, ethical, and legal questions. Conclusions and Relevance CRISPR-Cas9 is already having a substantial effect on cardiovascular basic science research. Although the first steps toward potential therapies have been taken, there are substantial obstacles that will need to be overcome if CRISPR-Cas9 is to be used in the practice of cardiovascular medicine.Keywords
This publication has 9 references indexed in Scilit:
- Faculty Opinions recommendation of A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.2017
- Faculty Opinions recommendation of Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.2016
- Faculty Opinions recommendation of Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy.2016
- Faculty Opinions recommendation of Multiplex genome engineering using CRISPR/Cas systems.2016
- Faculty Opinions recommendation of Rationally engineered Cas9 nucleases with improved specificity.2016
- Faculty Opinions recommendation of High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.2016
- Faculty Opinions recommendation of Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining.2015
- Faculty Opinions recommendation of Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing.2015
- Faculty Opinions recommendation of Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.2015